Immunity induced by a broad class of inorganic crystalline materials is directly controlled by their chemistry

Journal of Experimental Medicine

Volumn 211, Issue 6, 2014, Pages 1019-1025

  Williams, Gareth R ^a,b   Fierens, Kaat ^c,d   Preston, Stephen G ^b   Lunn, Daniel ^a   Rysnik, Oliwia ^b   De Prijck, Sofie ^c   Kool, Mirjam ^c,d,e   Buckley, Hannah C ^a,b   Lambrecht, Bart N ^c,d,e   O'Hare, Dermot ^a   Austyn, Jonathan M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HYDROXIDE; INORGANIC COMPOUND; LAYERED DOUBLE HYDROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PHENOMENA; PRIORITY JOURNAL; SYNTHESIS; VACCINATION;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CELLS, CULTURED; CRYSTALLIZATION; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROXIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIVARIATE ANALYSIS; OVALBUMIN;

EID: 84901750364     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131768     Document Type: Article

References (27)

1. Attwood, D. 2007. Disperse systems. In Aulton's Pharmaceutics: The Design And Manufacture of Medicines. Third edition. M.E. Aulton, editor. Elsevier Ltd, Philadelphia, PA. 76-78.
2. Becker, S., M.K. Warren, and S. Haskill. 1987. Colony-stimulating factorinduced monocyte survival and differentiation into macrophages in serumfree cultures. J. Immunol. 139:3703-3709.
3. Bianchi, M.E. 2007. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81:1-5. http://dx.doi.org/10.1189/jlb.0306164.
4. Coffman, R.L., A. Sher, and R.A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity. 33:492-503. http://dx.doi.org/ 10.1016/j.immuni.2010.10.002.
5. DeFranco, A.L. 2008. "Dangerous crystals". Immunity. 29:670-671. http:// dx.doi.org/10.1016/j.immuni.2008.10.005.
6. Dostert, C., V. Pétrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320:674-677. http://dx.doi.org/10.1126/science.1156995.
7. Eisenbarth, S.C., O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 453:1122-1126. http://dx.doi.org/10.1038/nature06939.
8. Flach, T.L., G. Ng, A. Hari, M.D. Desrosiers, P. Zhang, S.M. Ward, M.E. Seamone, A. Vilaysane, A.D. Mucsi, Y. Fong, et al. 2011. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17:479-487. http://dx.doi.org/10.1038/nm.2306.
9. Gavin, A.L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science. 314:1936-1938. http://dx.doi.org/ 10.1126/science.1135299.
10. Hornung, V., F. Bauernfeind, A. Halle, E.O. Samstad, H. Kono, K.L. Rock, K.A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9:847-856. http://dx.doi.org/10.1038/ni.1631.
11. Hu, G., and D. O'Hare. 2005. Unique layered double hydroxide morphologies using reverse microemulsion synthesis. J. Am. Chem. Soc. 127:17808-17813. http://dx.doi.org/10.1021/ja0549392.
12. Khan, A.I., A. Ragavan, B. Fong, C. Markland, M. O'Brien, T.G. Dunbar, G.R. Williams, and D. O'Hare. 2009. Recent Developments in the use of layered double hydroxides as host materials for the storage and triggered release of functional anions. Ind. Eng. Chem. Res. 48:10196-10205. http://dx.doi.org/10.1021/ie9012612.
13. Kool, M., V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I.M. Bergen, R. Castillo, B.N. Lambrecht, and J. Tschopp. 2008a. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181:3755-3759.
14. Kool, M., T. Soullié, M. van Nimwegen, M.A. Willart, F. Muskens, S. Jung, H.C. Hoogsteden, H. Hammad, and B.N. Lambrecht. 2008b. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205:869-882. http:// dx.doi.org/10.1084/jem.20071087.
15. Kwan, W.-H., E. Navarro-Sanchez, H. Dumortier, M. Decossas, H. Vachon, F.B. dos Santos, H.W. Fridman, F.A. Rey, E. Harris, P. Despres, and C.G. Mueller. 2008. Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl. Trop. Dis. 2:e311. http://dx.doi.org/10.1371/journal.pntd.0000311.
16. Li, A., L. Qin, W. Wang, R. Zhu, Y. Yu, H. Liu, and S. Wang. 2011. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials. 32:469-477. http://dx.doi.org/10.1016/j.biomaterials.2010.08.107.
17. Lide, D.R., editor. 2000. CRC Handbook of Chemistry and Physics. 81st edition. CRC Press, Boca Raton, FL. 2556 pp.
18. Marrack, P., A.S. McKee, and M.W. Munks. 2009. Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol. 9:287-293. http://dx.doi.org/10.1038/nri2510.
19. McKee, A.S., M.W. Munks, M.K. MacLeod, C.J. Fleenor, N. Van Rooijen, J.W. Kappler, and P. Marrack. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 183:4403-4414. http://dx.doi.org/10.4049/jimmunol.0900164.
20. Medzhitov, R. 2009. Approaching the asymptote: 20 years later. Immunity. 30:766-775. http://dx.doi.org/10.1016/j.immuni.2009.06.004.
21. Nakaya, H.I., and B. Pulendran. 2012. Systems vaccinology: its promise and challenge for HIV vaccine development. Curr. Opin. HIV AIDS. 7:24-31. http://dx.doi.org/10.1097/COH.0b013e32834dc37b.
22. Ng, G., K. Sharma, S.M. Ward, M.D. Desrosiers, L.A. Stephens, W.M. Schoel, T. Li, C.A. Lowell, C.-C. Ling, M.W. Amrein, and Y. Shi. 2008. Receptor-independent, direct membrane binding leads to cellsurface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 29:807-818. http://dx.doi.org/10.1016/j.immuni.2008.09.013.
23. Plotkin, S.A. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47:401-409. http://dx.doi.org/10.1086/589862.
24. Pulendran, B., and R. Ahmed. 2011. Immunological mechanisms of vaccination. Nat. Immunol. 12:509-517. http://dx.doi.org/10.1038/ni.2039.
25. Pulendran, B., S. Li, and H.I. Nakaya. 2010a. Systems vaccinology. Immunity. 33:516-529. http://dx.doi.org/10.1016/j.immuni.2010.10.006.
26. H2 and tolerogenic responses. Nat. Immunol. 11: 647-655. http://dx.doi.org/10.1038/ni.1894.
27. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118. http://dx.doi.org/10.1084/jem.179.4.1109.